Clinical Trial Update: Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemic Patients [NA]

View source ↗

Summary

A clinical trial evaluating omega-3 polyunsaturated fatty acid–supplemented products in adults with moderate hypertriglyceridemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• n-3 polyunsaturated fatty acids (PUFA)-supplemented products (Omega-3 fatty acids)

Snippet

Sponsor: University of Jena | Conditions: Hypertriglyceridemia | NA | Status: COMPLETED